What does Rigel Pharmaceuticals, Inc. do?

Jun 22 2025 06:13 PM IST
share
Share Via
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing small molecule drugs for immune and hematological disorders, cancer, and rare diseases. As of March 2025, it reported net sales of $53 million and a market cap of $342.44 million.
Overview:
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in discovering, developing, and providing novel small molecule drugs for immune and hematological disorders, cancer, and rare diseases, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 53 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 11 Million (Quarterly Results - Mar 2025)
Market-cap: USD 342.44 Million (Micro Cap)

Key Metrics:
P/E: 10.00
Dividend Yield: 0.00%
Debt Equity: -0.91
Return on Equity: 200.24%
Price to Book: 18.44

Contact Details:
Address: 1180 Veterans Blvd, SOUTH SAN FRANCISCO CA: 94080-1985
Tel: 1 650 6241100
Website: https://www.rigel.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News